tiprankstipranks
Enzon Pharmaceuticals Expands Board and Forms Strategic Committee
Company Announcements

Enzon Pharmaceuticals Expands Board and Forms Strategic Committee

Story Highlights

Stay Ahead of the Market:

An update from Enzon Pharmaceuticals ( (ENZN) ) is now available.

Enzon Pharmaceuticals has expanded its Board of Directors to four members and appointed Stephen T. Wills as a new director. Wills brings extensive experience from his roles at various biopharmaceutical and technology companies, contributing his expertise in financial and operational management. Additionally, Enzon’s Board has formed a special committee to explore strategic alternatives concerning a proposal from Viskase Companies, Inc. The committee, including Wills, has full authority to negotiate and evaluate any potential transactions, though no decisions have been made yet.

More about Enzon Pharmaceuticals

YTD Price Performance: -11.67%

Average Trading Volume: 71,998

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $11.85M

See more data about ENZN stock on TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles